Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.
about
Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsTranscriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species ComparisonThe transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicansGenetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infectionElucidating drug resistance in human fungal pathogens.Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.Detection of inhibitors of Candida albicans Cdr transporters using a diS-C3(3) fluorescence.Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1.Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.Milbemycins: more than efflux inhibitors for fungal pathogensDistinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulenceMechanisms of Antifungal Drug Resistance.Medically important fungi respond to azole drugs: an update.The development of fluconazole resistance in Candida albicans - an example of microevolution of a fungal pathogen.Fluconazole resistance in Candida species: a current perspective.Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.Antifungal resistance and new strategies to control fungal infections.The synthetic killer peptide KP impairs Candida albicans biofilm in vitro.Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.Update on Antifungal Drug Resistance.An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses.Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.Multilocus resistance evolution to azole fungicides in fungal plant pathogen populations.Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation.Candidacidal Activity of a Novel Killer Toxin from Wickerhamomyces anomalus against Fluconazole-Susceptible and -Resistant Strains.Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans.Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral c
P2860
Q26863344-96D205BE-A37B-47DE-A672-0B6DBD9EBDEAQ28079641-9078C6DF-FC6E-42A4-B621-332E9CE6677BQ28477254-82E326B4-31D2-4E1B-901B-3175AED21226Q33768787-3AD72552-C553-4DC9-85BD-1A6813127823Q34419351-AE147E37-06D4-417F-8CC6-67249998648BQ34932227-278F046D-42A4-4EC5-A41F-DFB06EBC47E5Q35158235-81A1CF01-3ADA-4905-AF31-6D20FB59D109Q35191806-E346FCC6-B80D-4300-A2EA-AA97DBEE2029Q36439061-D79D716C-CBE6-45FA-9FF4-4C8398AEF40CQ36558410-2299C6C1-D433-420B-84D5-16CD4A1DF051Q37545098-F23F8933-784A-4FCA-9454-3A18207F2DFAQ38266675-22F36F04-5B35-4AD0-8683-E47CE099AFA5Q38559208-A49D1B73-7598-4350-9424-84B3CCFCC55CQ38752384-66A51A6F-5EE7-49B4-AF92-27824A557D76Q39092120-B728DA71-41A4-4450-A860-BFE3D5B81CB6Q39279261-F9659C24-34EB-4B5C-8BEB-04A46AABC45BQ39670853-F4D98C60-2362-4CA2-BD29-85E72FFDABDCQ39751373-416BA1CD-03B6-459D-BB73-5ED1D2DA1C0BQ40136133-8FB0485A-F229-4C36-ACFA-E9C9A5431FF6Q40230670-0FDC607F-62D5-41BF-A13F-D52DF41A02B8Q41135029-3A6C8AA3-FC0D-4D14-A525-6623040A0C0EQ42708319-C5CFB690-6767-48BE-8C0E-C9E57B673EF9Q42735156-B1CC4EC0-1692-4861-A825-E2963D50F6E3Q43102374-730FEA31-C2E6-46B5-99BD-BC8AD5182F6AQ46458243-F364EADB-1F7B-4FD5-80D1-08C16E0605A7Q48026484-9A596AE4-BEF9-4393-A4D7-0AEA9267F153Q48105102-809F8949-3E5C-4454-8858-8D992621B7C8Q53111736-8A0BA744-5C11-4616-80B3-045C0425DFBBQ58490188-89F53C64-972A-4607-A93A-6BDE6B080211
P2860
Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional analysis of cis- an ...... ovel promoter reporter system.
@en
Functional analysis of cis- an ...... ovel promoter reporter system.
@nl
type
label
Functional analysis of cis- an ...... ovel promoter reporter system.
@en
Functional analysis of cis- an ...... ovel promoter reporter system.
@nl
prefLabel
Functional analysis of cis- an ...... ovel promoter reporter system.
@en
Functional analysis of cis- an ...... ovel promoter reporter system.
@nl
P2093
P2860
P356
P1433
P1476
Functional analysis of cis- an ...... novel promoter reporter system
@en
P2093
Bettina Rohde
Christopher Bauser
Jérôme Crittin
P2860
P304
P356
10.1128/EC.00069-09
P577
2009-06-26T00:00:00Z